Theravance Biopharma, Inc. Balance Sheet

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Assets
Current Assets
Cash & Equivalents 89.22M112.71M344.71M88.98M378.02M58.06M81.47M89.96M298.17M39.55M37.80M
Short-term Investments 165.40M59.73M156.39M259.59M127.25M222.77M211.47M83.51M29.31M62.88M50.55M
Cash & Current Investments 254.61M172.43M501.10M348.57M505.28M280.83M292.94M173.47M327.48M102.43M88.35M
Receivables - Net 0.20M0.29M1.92M0.65M2.25M0.62M
Receivables - Other 0.93M1.84M35.23M9.08M7.11M10.05M28.57M53.80M14.06M16.79M17.47M18.44M
Receivables 1.13M2.13M37.15M9.72M9.36M10.67M
Raw Materials 5.14M6.83M6.87M6.07M11.73M
Work In Process 0.36M0.14M2.63M0.07M
Finished Goods 4.91M5.57M3.14M3.53M5.04M
Inventory 10.41M12.55M10.01M12.22M16.83M
Prepaid Assets 2.57M6.08M12.76M3.06M3.70M11.45M4.35M10.36M8.56M7.68M11.60M4.28M
Current Assets 14.11M275.37M237.47M528.50M378.75M532.82M36.74M393.34M249.87M353.46M133.54M161.07M
Non-Current Assets
Property, Plant & Equipment (Net) 10.24M9.66M9.87M8.46M10.16M13.18M12.64M16.42M13.66M11.88M9.07M7.42M
Long-Term Investments 51.40M42.86M91.56M41.59M11.87M4.99M12.75M67.54M2.29M
Long-Term Deferred Tax 440.75M447.30M2.43M
Other Non-Current Assets 0.83M0.83M1.08M1.89M1.88M1.53M1.59M2.45M3.23M6.90M8.07M12.29M
Non-Current Assets 11.07M62.40M62.64M110.75M62.65M27.41M372.09M16.96M37.70M253.94M248.46M193.09M
Assets 25.18M337.77M300.12M639.25M441.40M560.24M408.83M469.06M374.82M607.40M382.00M354.16M
Liabilities
Current Liabilities
Accounts Payables 6.94M9.92M18.80M1.73M5.92M9.03M4.76M6.78M3.10M1.55M1.52M2.24M
Payables 6.94M9.92M18.80M1.73M5.92M9.03M4.76M6.78M3.10M1.55M1.52M2.24M
Accumulated Expenses 9.87M18.16M10.87M14.02M24.14M23.80M28.18M35.24M12.80M10.31M6.44M7.02M
Other Accumulated Expenses 9.71M5.22M4.95M8.30M11.71M7.36M1.94M2.01M1.30M1.14M1.24M2.21M
Short term Debt 9.85M19.33M16.94M
Current Leases 7.76M9.87M0.50M6.75M3.92M10.71M
Current Taxes 5.85M
Current Deferred Revenue 8.21M0.09M0.14M0.15M0.12M43.40M31.57M11.52M0.10M0.02M
Total Current Liabilities 36.85M41.26M49.47M49.27M62.55M98.55M3.07M123.57M58.59M28.71M24.77M32.09M
Non-Current Liabilities
Non-Current Debt 229.53M219.30M372.87M371.36M
Convertible Debt 222.68M223.75M224.82M225.89M226.96M228.03M
Non-Current Deffered Revenue 4.77M5.15M4.60M3.97M3.67M26.18M6.76M0.35M0.31M0.19M
Operating Leases 47.73M47.22M52.68M45.41M45.24M39.11M
Other Non-Current Liabilities 0.58M1.58M2.98M13.11M34.82M24.76M21.29M63.45M75.02M76.00M79.50M1.89M
Total Non-Current Liabilities -0.58M-1.58M-2.98M-13.11M-34.82M-24.76M-21.29M-63.45M-75.02M-76.00M-79.50M-1.89M
Shareholder's Equity
Total Debt 229.53M229.15M392.21M388.30M
Common Equity -6.99M-17.04M289.79M243.06M350.23M115.18M-51.59M-223.84M-303.75M-338.57M441.80M213.00M175.54M
Shareholder's Equity -6.99M-17.04M289.79M243.06M350.23M115.18M-51.59M-223.84M-303.75M-338.57M441.80M213.00M175.54M
Liabilities and Shareholders Equity 25.18M337.77M300.12M639.25M441.40M560.24M408.83M469.06M374.82M607.40M382.00M354.16M
Retained Earnings -139.34M-321.56M-512.23M-797.74M1.12M-1248.60M-1526.62M-1726.04M-853.91M-909.10M-965.52M
Treasury Shares 2.99M3.61M2.90M3.07M4.94M4.99M8.35M12.74M4.00M3.96M